跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,490 条关于
“enteric hyperoxaluria”
全部
2,490
临床试验
1,525
药物
78
机构
21
资讯
866
去年
Synlogic's Novel Probiotic Therapy Shows Promise in Phase 2 PKU Trial, Advancing to Phase 3
去年
Engineered Gut Bacteria Shows Promise in Phase 1/2a Trial for Kidney Stone Prevention
去年
YolTech's YOLT-203 Shows Promise in Primary Hyperoxaluria Type 1 with Positive Clinical Data
去年
Primary Hyperoxaluria Pipeline Shows Promise with 6+ Therapies in Development as Gene Editing Advances
3个月前
Tap Water May Be the Safest Choice for Enteric-Coated Medications, Study Finds
2个月前
ABO-101 Gene Editing Therapy for Primary Hyperoxaluria Type 1 Granted Orphan Drug Designation by European Commission
2个月前
Everest Medicines and Hainan Herui Forge Commercialization Partnership for Budesonide Enteric Capsules in China
去年
Arbor Biotechnologies' ABO-101 Receives FDA Clearance for Phase 1/2 Trial in Primary Hyperoxaluria Type 1
2年前
First Patients Dosed in Phase 1 Trial of In Vivo CRISPR Therapy YOLT-203 for Primary Hyperoxaluria Type 1
10个月前
YolTech Therapeutics Receives FDA Clearance for First Pivotal Trial of In Vivo Gene-Editing Therapy for Primary Hyperoxaluria Type 1
第 1 页,共 87 页
上一页
下一页